Dear Colleagues,

Drug delivery systems are technologies developed for the dosing, targeted delivery, or prolonged and controlled release of therapeutic agents. Interdisciplinary research has advanced our understanding of the physiological barriers and transport mechanisms and contributed to design systems capable of overcoming such barriers and effectively delivering their cargo. Drug delivery has changed dramatically in recent years, and it is foreseeable that the changes will be even greater with the use of nanotechnology, which allows for improving the transport, bioavailability, and distribution of theragnostic agents. However, there are still challenges to overcome, like the side effects of chemotherapeutics on healthy tissue, targeting strategies, crossing the blood–brain barrier, enhancing intracellular delivery, improving transport mechanisms in the body, and scalability, among others. Despite the current advances, there are still limitations to designing optimal drugs for many diseases such as cancer, heart disease, neurodegenerative or infectious diseases and even poisoning.

This Special Issue aims to encourage researchers to submit significant and original work related to all aspects of drug delivery systems. Research or review papers are welcome that address fundamentals to micro/nano applications, as well as related materials, devices, and systems that contribute to overcoming the severe limitations of current medical practice and contribute to scientific progress for the prevention, management, and control of health problems. Potential topics include but are not limited to:

• Synthesis and characterization of micro/nanoparticles;
• Application of nanoplatforms as drug carriers;
• Surface modification or functionalization of systems for targeted delivery;
• Devices or alternative methods for drug delivery;
• Theranostics platforms;
• In vitro or in vitro studies of drug delivery systems.

Prof. Dr. Christian Chapa
Prof. Dr. Perla Elvia García Casillas
Dr. Roberto Carlos Carrillo Torres
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanomedicine
• micro/nanomaterials for drug delivery
• biomedical and biomolecular materials
• theranostic platforms
• micro/nano fabrication and manufacturing medical devices
• encapsulation efficiency
• drug release
• cellular uptake
• targeted delivery